Cough Miniseries – Episode 3: Treatment Options Cough

In the third of three podcasts focusing on Cough, host Dr. Purvi Parikh joins with Dr. Kevin Murphy and Dr. Mandel Sher to look at the what does and doesn’t work in treating cough. They review the current therapies and what new therapies options are coming in the future.

This podcast is supported by an educational grant from Merck & Co., Inc.

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Kevin Murphy, MD
Honoraria: AstraZeneca, Genentech, Novartis, Sanofi, Regeneron

Purvi Parikh, MD

Honoraria: AstraZeneca, Takeda, Genentech/Novartis, Aimmune; Contracted research: AstraZeneca

Mandel Sher, MD

Advisory Committee, Consulting Fee: Merck; Speaker, Honorarium: Optinose; Consulting, Fee: NeRRe; Clinical Investigator, Contracted Research: Attenua, Merck, NeRRe